Literature DB >> 25540994

Total joint arthroplasty in transplant recipients: in-hospital adverse outcomes.

Priscilla K Cavanaugh1, Antonia F Chen1, Mohammad R Rasouli1, Zachary D Post1, Fabio R Orozco1, Alvin C Ong1.   

Abstract

This study aims to determine in-hospital complications and mortality in transplant recipients following total joint arthroplasty. The Nationwide Inpatient Sample database was queried for patients with history of transplant and joint arthroplasty (primary or revision) from 1993 to 2011. Kidney transplant increased risk of surgical site infection (SSI) and wound infections (OR=2.03), systemic infection (OR=2.85), deep venous thrombosis (OR=2.07), acute renal failure (ARF) (OR=3.48), respiratory (OR=1.34), and cardiac (OR=1.21) complications. Liver transplant was associated with SSI/wound infections (OR=2.32), respiratory complications (OR=1.68), cardiac complications (OR=1.34), and ARF (OR=4.48). Other transplants grouped together were associated with wound complications (OR=2.13), respiratory complications (OR=2.06), and ARF (OR=4.42). Our study suggests these patients may be at increased risk of in-hospital complications, particularly ARF in renal and liver transplant patients.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Keywords:  complications; organ transplant; renal transplant; total hip arthroplasty; total knee arthroplasty

Mesh:

Year:  2014        PMID: 25540994     DOI: 10.1016/j.arth.2014.11.037

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  9 in total

1.  What Is the Timing of General Health Adverse Events That Occur After Total Joint Arthroplasty?

Authors:  Daniel D Bohl; Nathaniel T Ondeck; Bryce A Basques; Brett R Levine; Jonathan N Grauer
Journal:  Clin Orthop Relat Res       Date:  2017-12       Impact factor: 4.176

2.  Hypothyroidism Increases 90-Day Complications and Costs Following Primary Total Knee Arthroplasty.

Authors:  Leonard T Buller; Samuel Rosas; Karim G Sabeh; Martin W Roche; Alexander S McLawhorn; Wael K Barsoum
Journal:  J Arthroplasty       Date:  2017-11-06       Impact factor: 4.757

3.  Total joint arthroplasty following solid organ transplants: complications and mid-term outcomes.

Authors:  Christine J Wu; Adam C Brekke; Zoe W Hinton; Billy I Kim; Sean P Ryan; Michael P Bolognesi; Thorsten M Seyler
Journal:  Int Orthop       Date:  2022-10-12       Impact factor: 3.479

4.  Complications, demographics and hospital stay in organ transplant patients undergoing total hip arthroplasty - A national database study between 2016 and 2019.

Authors:  Sushrruthi Varatharaj; Tejas Senthil; Vibhu Krishnan Viswanathan; Vishaal Sakthivelnathan; Varatharaj Mounasamy; Senthil Sambandam
Journal:  J Orthop       Date:  2022-09-01

5.  Post-operative medical and surgical complications after primary total joint arthroplasty in solid organ transplant recipients: a case series.

Authors:  Andrew C Palmisano; Andrew W Kuhn; Andrew G Urquhart; Aidin Eslam Pour
Journal:  Int Orthop       Date:  2016-08-06       Impact factor: 3.075

6.  Arthroplasty in organ transplant patients.

Authors:  Brian T Nickel; Cameron K Ledford; Tyler Steven Watters; Samuel S Wellman; Michael P Bolognesi
Journal:  Arthroplast Today       Date:  2015-06-19

7.  Total hip arthroplasty in patients with chronic liver disease: A systematic review.

Authors:  Elliot Onochie; Babar Kayani; Sebastian Dawson-Bowling; Steven Millington; Pramod Achan; Sammy Hanna
Journal:  SICOT J       Date:  2019-11-04

8.  Short-Term Outcomes of Total Hip Arthroplasty after Liver Transplantation.

Authors:  Akihito Oya; Taro Umezu; Ryo Ogawa; Toru Nishiwaki; Yasuo Niki; Masaya Nakamura; Morio Matsumoto; Arihiko Kanaji
Journal:  Arthroplast Today       Date:  2021-02-23

9.  Postoperative outcomes of kidney transplant recipients undergoing non-transplant-related elective surgery: a systematic review and meta-analysis.

Authors:  Dharmenaan Palamuthusingam; Kuhan Kunarajah; Elaine M Pascoe; David W Johnson; Camel M Hawley; Magid Fahim
Journal:  BMC Nephrol       Date:  2020-08-25       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.